Latest Features & Opinion
INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
A collection of news, case studies, and feature articles focused on the diagnosis and management of infection processes in patients with immune systems impaired by an underlying disease.
Middle-aged woman who received a heart transplant 1 year ago because of dilated cardiomyopathy now presents with mild fever and generalized weakness.
It is important to understand the relative severity of CDI in patients in the ICU because it effects treatment decisions. However, primary prevention remains a vitally important strategy to limit morbidity and mortality related to CDI in this vulnerable patient population.
Dr McKinnell provides a summary of drugs in development for infections caused by Gram-negative bacteria, including carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Clinicians Warn That Zika Virus May Still Be an Area of Concern for Travelers
- Fixed-Dose Bictegravir, Emtricitabine, Tenofovir Alafenamide Is Efficacious HIV-1 Treatment Option
- Ceftazidime/Avibactam an Effective Option in Serious Gram-Negative Infections
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- Mosaic HIV-1 Vaccine Induces Responses in Humans and Monkeys
- Universal Purchase Programs in the United States May Not Effectively Increase Vaccination Rates
- Tick-Caused Meat Allergy on the Rise in the United States
- Delays in Lactate Testing Associated With Delayed Antibiotics, Increased Mortality in Sepsis
- Prognostic Biomarkers to Guide Antibiotic Therapy in Critically Ill Patients
- Sofosbuvir/Velpatavir Effective for HCV-Infected Liver Transplant Recipients
- Factors Increasing Risk for Hemorrhagic Stroke After Infective Endocarditis
- Salmonella Outbreak Linked to Hy-Vee Spring Pasta Salad
- Harms Reporting Limited in Trials of Prebiotics, Probiotics, Synbiotics
- Trials Supporting FDA Approval of Breakthrough Drugs Examined
- Etravirine Indication Expanded to Include Younger HIV Patients